Cancer and Translational Research Lab, Department of Biotechnology, Dr. D. Y. Patil Biotechnology & Bioinformatics Institute, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, 411033, India.
Mol Biol Rep. 2019 Jun;46(3):3607-3612. doi: 10.1007/s11033-019-04770-2. Epub 2019 Mar 22.
Driven by the heterogeneous and complex nature of HIV-1 infection and tumors, the possibilities of viable cross-talk are facilitated by the intra-cellular and inter-cellular signaling regimens. There are evidences that support the clear role of exosomes containing TAR RNAs that are secreted by HIV-1 infected cells and these TAR RNA brings pro-growth and pro-survival effects upon cancer cells. Recently, the regulatory role of TAR RNAs in the intra-cellular signaling network is shown that augments cancer cells to achieve tremendous progression and malignancy. In this paper, author highlights the role of HIV-1 infected cells secreted exosomes containing TAR RNA in tumor hallmarks. Further, this paper provides future insights on new classes of cancer therapeutics centered on disrupting exosomes and TAR RNA.
受 HIV-1 感染和肿瘤的异质性和复杂性的驱动,细胞内和细胞间信号方案促进了可行的串扰的可能性。有证据表明,HIV-1 感染细胞分泌的含有 TAR RNA 的外泌体在促进癌细胞生长和存活方面发挥着明确的作用。最近,TAR RNA 在细胞内信号网络中的调节作用表明,它增强了癌细胞的巨大进展和恶性程度。在本文中,作者强调了 HIV-1 感染细胞分泌的含有 TAR RNA 的外泌体在肿瘤特征中的作用。此外,本文还对以破坏外泌体和 TAR RNA 为中心的新型癌症治疗药物提供了未来的见解。